Annual report
7681.TEDINET S100V0D2
Period2023-10-01 → 2024-09-30
Filed2024-12-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100UYNL. Amended by S100V0EI (2024-12-25).
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥26.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥29.8bn | 2021-10-01 → 2022-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.3bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.0bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥178m | 2023-10-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥440m | 2022-10-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥181m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥710m | 2021-10-01 → 2022-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥596m | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥207m | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥274m | 2023-10-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥432m | 2022-10-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥271m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥437m | 2021-10-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥391m | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥121m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥155m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥286m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥10.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥14.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥13.5bn | at 2022-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.0bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.4bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥9.0bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.7bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.5bn | at 2022-09-30d | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2021-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥4.8bn | at 2020-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.4bn | at 2021-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.4bn | at 2020-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥33m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥342m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥242m | 2021-10-01 → 2022-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.9bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥101m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥82m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥50m | 2021-10-01 → 2022-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥42m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥64m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥97m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥202m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥121m | 2021-10-01 → 2022-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥298m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥238m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥23.09 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.12 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.3 | 2021-10-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.64 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.84 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.96 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥45.84 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.84 | 2021-10-01 → 2022-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥66.11 | 2020-10-01 → 2021-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥20.62 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥943.51 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥946.33 | at 2023-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥915.42 | at 2022-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥855.78 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥802.93 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 52.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2022-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.1% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 2.4% | 2023-10-01 → 2024-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.0% | 2022-10-01 → 2023-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2021-10-01 → 2022-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2020-10-01 → 2021-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 170 | at 2024-09-30 | Cons. | Number of employees |
| Employees | 176 | at 2023-09-30 | Cons. | Number of employees |
| Employees | 175 | at 2022-09-30d | Cons. | Number of employees |
| Employees | 162 | at 2021-09-30d | Cons. | Number of employees |
| Employees | 157 | at 2020-09-30d | Cons. | Number of employees |
| Revenue | ¥17.4bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥24.0bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥27.3bn | 2021-10-01 → 2022-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥23.4bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥19.7bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥40m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Operating income | ¥317m | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Ordinary income | −¥16m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥362m | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥448m | 2021-10-01 → 2022-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥435m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥234m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥77m | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥362m | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Net income | ¥44m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥269m | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | ¥294m | 2021-10-01 → 2022-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥297m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥194m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.5bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥13.7bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥12.3bn | at 2022-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.7bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.3bn | at 2024-09-30 | Standalone | Liabilities |
| Total liabilities | ¥8.5bn | at 2023-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.1bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.2bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2022-09-30d | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.6bn | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.5bn | at 2024-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥7.52 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.7 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.91 | 2021-10-01 → 2022-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.54 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.53 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥7.48 | 2023-10-01 → 2024-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥45.42 | 2022-10-01 → 2023-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥49.6 | 2021-10-01 → 2022-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.14 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.18 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2023-10-01 → 2024-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-10-01 → 2023-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-10-01 → 2022-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2020-10-01 → 2021-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥865.93 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥884.07 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥853.57 | at 2022-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥818.33 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥781.47 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 54.0% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2022-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.9% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2022-10-01 → 2023-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2021-10-01 → 2022-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,967,800 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,960,800 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,960,800 | at 2022-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,960,800 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,954,400 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 134 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 137 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 134 | at 2022-09-30d | Standalone | Number of employees |
| Employees | 118 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 114 | at 2020-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | −¥17,000 |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | −¥146m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | ¥2m |
| Food Servicereportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥3m |
| Food Servicereportable segment | employees | at 2024-09-30 | 9 pure |
| Food Servicereportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥416m |
| Food Servicereportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥416m |
| Food Servicereportable segment | segment assets | at 2024-09-30 | ¥191m |
| Food Servicereportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥14m |
| Remote Image Diagnosis Service Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥7m |
| Remote Image Diagnosis Service Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥21m |
| Remote Image Diagnosis Service Businessreportable segment | employees | at 2024-09-30 | 13 pure |
| Remote Image Diagnosis Service Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥778m |
| Remote Image Diagnosis Service Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥778m |
| Remote Image Diagnosis Service Businessreportable segment | segment assets | at 2024-09-30 | ¥624m |
| Remote Image Diagnosis Service Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥67m |
| Total Medical Solution Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥37m |
| Total Medical Solution Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥76m |
| Total Medical Solution Businessreportable segment | employees | at 2024-09-30 | 148 pure |
| Total Medical Solution Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥18.6bn |
| Total Medical Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥18.6bn |
| Total Medical Solution Businessreportable segment | segment assets | at 2024-09-30 | ¥10.0bn |
| Total Medical Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥95m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥100m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥19.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-09-30 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥176m |
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | −¥26,000 |
| Reconciling Itemsreconciling | segment assets | at 2023-09-30 | −¥146m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | ¥2m |
| Food Servicereportable segment | capex | 2022-10-01 → 2023-09-30 | ¥552,000 |
| Food Servicereportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥4m |
| Food Servicereportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥404m |
| Food Servicereportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥404m |
| Food Servicereportable segment | segment assets | at 2023-09-30 | ¥198m |
| Food Servicereportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥11m |
| Remote Image Diagnosis Service Businessreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥50m |
| Remote Image Diagnosis Service Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥20m |
| Remote Image Diagnosis Service Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥725m |
| Remote Image Diagnosis Service Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥725m |
| Remote Image Diagnosis Service Businessreportable segment | segment assets | at 2023-09-30 | ¥545m |
| Remote Image Diagnosis Service Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥56m |
| Total Medical Solution Businessreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥30m |
| Total Medical Solution Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥81m |
| Total Medical Solution Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥25.5bn |
| Total Medical Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥25.5bn |
| Total Medical Solution Businessreportable segment | segment assets | at 2023-09-30 | ¥14.1bn |
| Total Medical Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥371m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-10-01 → 2023-09-30 | ¥81m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-10-01 → 2023-09-30 | ¥104m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-09-30 | ¥26.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-09-30 | ¥26.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-09-30 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-09-30 | ¥438m |
| Total Medical Solution Businessreportable segment | employees | at 2024-09-30 | 134 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,398
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_NonConsolidatedMember | 5111711000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 860725000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 870756000 | JPY |
| Provision for bonuses sga | Prior1YearDuration_NonConsolidatedMember | 85755000 | JPY |
| Provision for bonuses sga | CurrentYearDuration_NonConsolidatedMember | 84646000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration_NonConsolidatedMember | 37894000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | 30821000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration_NonConsolidatedMember | 17767000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration_NonConsolidatedMember | 32650000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 50697000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 50927000 | JPY |
| Traveling and transportation expenses sga | Prior1YearDuration_NonConsolidatedMember | 189142000 | JPY |
| Traveling and transportation expenses sga | CurrentYearDuration_NonConsolidatedMember | 190043000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration_NonConsolidatedMember | 1297000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration_NonConsolidatedMember | -112000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書(2024年12月25日付け訂正報告書の添付インラインXBRL） | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-12-19 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第24期(自 2023年10月１日 至 2024年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社レオクラン | |
| Company name in english cover page | FilingDateInstant | LEOCLAN Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 竹内 興次 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪府摂津市千里丘二丁目４番26号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 06-6387-1554 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役管理本部副本部長 西本 篤史 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪府摂津市千里丘二丁目４番26号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 06-6387-1554 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役管理本部副本部長 西本 篤史 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E34455 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 76810 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社レオクラン | |
| Filer name in english | FilingDateInstant | LEOCLAN Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2023-10-01 | |
| Current period end date | FilingDateInstant | 2024-09-30 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2022-10-01 | |
| Comparative period end date | FilingDateInstant | 2023-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-09-30 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |